Alopecia Market

1
Alopecia Market To Reach USD 12.99 Billion By
2026
www.reportsanddata.com
2
Market Summary
Rising incidences of chronic disorders such as
hyperthyroidism, acute stress disorder
hypopituitarism, hypothyroidism, and lupus are
the major factors influencing market
growth. Market Size USD 8.64 billion in 2018,
Market Growth - CAGR of 5.1, Market Trends
Increase in disposable income coupled with
rising concern about aesthetic appearance The
Alopecia Market is expected to reach USD 12.99
Billion by 2026, according to a new report by
Reports and Data. This can be mainly associated
with rising predominance of chronic disorders
such as hyperthyroidism, hypothyroidism, acute
stress disorder, lupus, and hypo pituitarism.
Moreover, increasing incidence of Hodgkins
disease, Hashimotos disease, Addisons disease,
and celiac disease along with factors such as
access to quick treatment are expected to drive
the market growth. However, high cost of
treatment and adverse side effects is expected to
restrain the growth. Also, changing lifestyle
such as consumption of tobacco, an increase in
the use of alcohol, and other associated
products, growing stress levels, and the
expanding population are expected to spur the
market. Increasing disposable incomes coupled
with the expanding emphasis on aesthetic
appearance are also likely to add to the demand
for alopecia treatment worldwide.
www.reportsanddata.com
3
Market Summary
The rising number of introduction of new drugs,
consumer disposable incomes, and the
complementary initiatives taken by the relevant
organizations namely, AHLA and NAAF, are the
crucial factors for the North America region to
account for the largest market share of 22.30 in
2018. Hair loss, also acknowledged as alopecia
or baldness refers to a loss of hair from part of
the head. The typical pattern of hair loss can
vary from a small area to the entire body.
Scarring or inflammation is not present. Hair
loss in some people may cause psychological
distress. General types include female-pattern
hair loss, male-pattern hair loss, alopecia
areata, and a thinning of hair also known as
telogen effluvium. The cause of male-pattern hair
loss is a combination of male hormones and
genetics, the purpose of female pattern hair loss
is not clear, the use of alopecia areata is
auto-immune, and the cause of telogen effluvium
is mostly a psychologically or physically
stressful event. Avail the inside scoop of the
Sample report _at_ https//www.reportsanddata.com/sam
ple-enquiry-form/1334
www.reportsanddata.com
4
Market Summary

• Further key findings from the report suggest
• Alopecia areata is an autoimmune skin disease
  identified by the hair loss on the scalp, face,
  and other areas of the body. Alopecia areata is
  segmented into totalis, patchy, and universalis
  further.
• Increasing predominance coupled with rising
  awareness regarding aesthetic appeal and physical
  appearance is also assumed to drive the growth in
  the next few years.
• Androgenetic type accounts for the largest market
  share of 42.20 in 2018 and is estimated to reach
  USD 5.51 billion by 2026.
• Also, the availability of treatments such as oral
  treatments, licensed topical treatments involving
  the use of finasteride and minoxidil and
  surgical procedures such as hair replacement and
  transplantation are expected to drive the market.
• Click here to avail the report at discount rate
  https//www.reportsanddata.com/discount-enquiry-fo
  rm/1334

www.reportsanddata.com
5
Market Summary

• Key participants include Cipla Inc., Johnson and
  Johnson AG, Transitions Hair Pty Ltd., Sun
  Pharmaceutical Industries Ltd., Merck Co.,
  Inc., Cirrus Hair Centers, Lexington
  International LLC, Vita-Cos-Med Klett-Loch GmbH,
  Follica, Inc., and Capillus.
• For the purpose of this study, Reports and Data
  have segmented the global Alopecia Market on the
  basis of Disease, Gender, application, Sales
  distribution and region
• Disease Outlook (Revenue, USD Million 2016-2026)
• Alopecia Areata
• Androgenetic Alopecia
• Others
• Sales distribution Outlook (Revenue, USD Million
  2016-2026)
• Prescriptions
• OTC
• To read the full report now, with industry-wide
  coverage, visit https//www.reportsanddata.com/ch
  eckout-form/1334

www.reportsanddata.com
6
Market Summary

• Application Outlook (Revenue, USD Million
  2016-2026)
• Homecare Settings
• Dermatology Clinics
• Gender Outlook (Revenue, USD Million 2016-2026)
• Female
• Male
• Regional Outlook (Revenue, USD Million
  2016-2026)
• North America
• Europe
• Asia Pacific
• Middle East Africa
• Latin America

www.reportsanddata.com
7
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer
market intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact US
John Watson Head of Business Development Reports
And Data Web www.reportsanddata.com Direct
Line 1-212-710-1370 E-mail sales_at_reportsanddata
.com
www.reportsanddata.com